ClinicalTrials.gg
CompletedNCT00669188Updated Aug 12, 2024

Patient Provider Communication and Interaction in a Virtual Clinical Setting

An interventional study of Information absent and Information in Healthy Volunteer, sponsored by National Human Genome Research Institute (NHGRI). Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-12.

Sponsored by National Human Genome Research Institute (NHGRI) · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
326
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Summary:

A few studies have explored factors which influence patient-provider communication in a controlled setting. However, more information is needed about how different factors affect communication so that it can be improved.

Third- and fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.

At the research center, participants will use a virtual reality headset to view a virtual clinic environment and interact with a virtual patient.

After interacting with the virtual patient, participants will complete a questionnaire about their experience within the virtual clinic and other research-related information.

The total time for the study visit is 60 minutes.

Eligibility:

Third- and fourth-year medical students at least 18 years of age. You may not take part in the study if you have a history of seizures and/or are pregnant.

Read the detailed description

This study will investigate research questions regarding factors influencing patient-provider communication. Participants will interact with a virtual patient in a virtual clinical setting.

Third- or fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.

Study participants will perform one task and complete one set of questions at the study appointment. The task involves viewing a virtual patient s health information and interacting with the virtual patient in a virtual environment clinical scenario. While in the virtual environment, the subject wears a head-mounted video unit that allows him or her to see elements of the environment. The activities in the virtual environment take about 15 minutes. The total time for the study is about 60 minutes.

02

Conditions studied

  • Healthy Volunteer

Keywords

  • Healthy Volunteer
03

In context

Lead sponsor

National Human Genome Research Institute (NHGRI) is the lead sponsor of 203 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

  • INCLUSION CRITERIA:

Healthy adult volunteers who are third or fourth-year medical students. Both men and women over age 18 will be eligible for this study (though in practice the age range is likely to naturally be constrained by the typical age of medical students).

EXCLUSION CRITERIA: 1) persons with seizure or vestibular disorders; 2) women with known pregnancy; 3) persons who are highly prone to motion sickness; 4) those with low, uncorrected vision or hearing; 5) all current and past employees and contractors of

NHGRI; and 6) persons who have received information about the study purpose or procedure from a past participant.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
326 participants (actual)

Study arms

  • Experimental
    Information Type 1

    genetic risk information

    Other: Information

  • Sham comparator
    Information Type 2

    information absent

    Other: Information absent

Interventions

  • OtherInformation absent

    Information

  • OtherInformation

    Information

06

What researchers measure

Primary outcomes

  1. treatment recommendations

    recommendations made for the virtual patient's treatment

    Time frame: at time of study

07

Study locations

1 site
  • National Institutes of Health Clinical Center
    Bethesda, Maryland 20892, United States
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2008 to primary completion in Jul 2020, 146 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 29, 2008
First posted
Apr 30, 2008
StartActual
Apr 24, 2008
Primary completionActual
Jul 8, 2020
CompletionActual
Jul 8, 2020
Last update
Aug 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00669188
Responsible party
Sponsor
First posted
Apr 30, 2008
Start date
Apr 24, 2008
Primary completion
Jul 8, 2020
Completion
Jul 8, 2020
Last update
Aug 12, 2024

Study contacts

Susan Persky, Ph.D.
principal investigator · National Human Genome Research Institute (NHGRI)

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion